Premium
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis
Author(s) -
Poore T. Spencer,
VirellaLowell Isabel,
Guimbellot Jennifer S.
Publication year - 2018
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.24043
Subject(s) - medicine , cystic fibrosis , stenotrophomonas maltophilia , meropenem , population , clindamycin , microbiology and biotechnology , intensive care medicine , antibiotics , pseudomonas aeruginosa , biology , bacteria , antibiotic resistance , environmental health , genetics
Abstract Presentation Patient is a 6‐year‐old male with CF, MRSA colonization, and pancreatic insufficiency that presented with worsening ppFEV1 and systemic symptoms despite multiple interventions. BAL grew NTM, Stenotrophomonas maltophilia , and Inquilinus limosus , a rare organism found in patients with CF. Course I. limosus treatment was deferred. Despite treatment of other pathogens, symptoms worsened. I. limosus was targeted with meropenem, amikacin, and ciprofloxacin along with clindamycin for MRSA colonization. Within weeks, symptoms had resolved with ppFEV1 improvement. Discussion This case discusses the importance of a rare organism in the CF population. Targeting I . limosus was key to recovery, revealing its potential pathogenicity.